La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Hansoh Pharmaceutical Group Salute del bilancio
Salute finanziaria criteri di controllo 5/6
Hansoh Pharmaceutical Group ha un patrimonio netto totale di CN¥25.8B e un debito totale di CN¥4.2B, che porta il suo rapporto debito/patrimonio netto a 16.4%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥33.0B e CN¥7.2B. L'EBIT di Hansoh Pharmaceutical Group è CN¥2.7B rendendo il suo rapporto di copertura degli interessi -2.8. Ha liquidità e investimenti a breve termine pari a CN¥24.9B.
Informazioni chiave
16.4%
Rapporto debito/patrimonio netto
CN¥4.22b
Debito
| Indice di copertura degli interessi | -2.8x |
| Contanti | CN¥24.88b |
| Patrimonio netto | CN¥25.79b |
| Totale passività | CN¥7.24b |
| Totale attività | CN¥33.04b |
Aggiornamenti recenti sulla salute finanziaria
Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Jun 24
Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28Recent updates
Pinning Down Hansoh Pharmaceutical Group Company Limited's (HKG:3692) P/E Is Difficult Right Now
Aug 07If EPS Growth Is Important To You, Hansoh Pharmaceutical Group (HKG:3692) Presents An Opportunity
Jul 16Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Jun 24Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 06Estimating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
May 23Hansoh Pharmaceutical Group Company Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 01Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?
Mar 28There's Reason For Concern Over Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Massive 28% Price Jump
Mar 04An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 28% Undervalued
Feb 16Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Quite Sensibly
Dec 08Hansoh Pharmaceutical Group Company Limited (HKG:3692) Shares Could Be 25% Below Their Intrinsic Value Estimate
Oct 12Hansoh Pharmaceutical Group's (HKG:3692) Upcoming Dividend Will Be Larger Than Last Year's
Sep 14These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Sep 09Calculating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jul 10These 4 Measures Indicate That Hansoh Pharmaceutical Group (HKG:3692) Is Using Debt Reasonably Well
Jun 11Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jan 23Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Dec 01Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 65% Above Its Share Price
Oct 19Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Aug 28An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 44% Undervalued
Jun 09Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Popularity With Investors Is Under Threat From Overpricing
May 19Is Hansoh Pharmaceutical Group (HKG:3692) A Risky Investment?
Apr 22An Intrinsic Calculation For Hansoh Pharmaceutical Group Company Limited (HKG:3692) Suggests It's 45% Undervalued
Feb 06Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 43% Above Its Share Price
Nov 07Hansoh Pharmaceutical Group (HKG:3692) Has A Rock Solid Balance Sheet
Oct 11A Look At The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Jul 14Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( CN¥28.9B ) di 3692 superano le sue passività a breve termine ( CN¥6.9B ).
Passività a lungo termine: Le attività a breve termine di 3692 ( CN¥28.9B ) superano le sue passività a lungo termine ( CN¥381.5M ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 3692 ha più liquidità del suo debito totale.
Riduzione del debito: Il rapporto debito/patrimonio netto di 3692 è aumentato da 0% a 16.4% negli ultimi 5 anni.
Copertura del debito: Il debito di 3692 è ben coperto dal flusso di cassa operativo ( 73.8% ).
Copertura degli interessi: 3692 matura più interessi di quanti ne paga, quindi la copertura dei pagamenti degli interessi non è un problema.